John Johnson - Director at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
XERS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John Johnson since 12/23/2023

Holdings reported by John Johnson for Xeris Biopharma Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 891K $1.7M $1.91 Jun 5, 2024 Direct
Stock Option (Right to Buy) 0 Mar 18, 2024 Direct Common Stock

Transactions reported by John Johnson for Xeris Biopharma Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.